Mice that were injected intraperitoneally with 100 g P9* showed weight loss and a decrease in glucose intolerance
Semaglutide reduces appetite, but what you eat still determines your weight loss speed and whether you maintain results long-term
A: Semaglutide is a single GLP-1 receptor agonist, while Tirzepatide is a dual GLP-1/GIP receptor agonist
However, it's important to note that while Ozempic and some weight loss medications contain the same or similar ingredients, Ozempic is only approved for managing type 2 diabetes, not for weight loss
Why Intermittent Fasting is a "Gentle" Start For many Americans, intermittent fasting serves as a low-cost entry point to health because it requires no prescriptions and allows you to eat "normal" foods
PlexusDx helps you navigate GLP-1 treatment with personalized dosing and genetic insights to minimize disruptions to your daily life